463 related articles for article (PubMed ID: 27889826)
1. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
Nissen CB; Hørslev-Petersen K; Primdahl J
Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden.
Landgren AJ; Dehlin M; Jacobsson L; Bergsten U; Klingberg E
RMD Open; 2021 May; 7(2):. PubMed ID: 34031261
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.
Mok CC; Ko GT; Ho LY; Yu KL; Chan PT; To CH
Arthritis Care Res (Hoboken); 2011 Feb; 63(2):195-202. PubMed ID: 20890981
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Han C; Robinson DW; Hackett MV; Paramore LC; Fraeman KH; Bala MV
J Rheumatol; 2006 Nov; 33(11):2167-72. PubMed ID: 16981296
[TBL] [Abstract][Full Text] [Related]
7. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.
Urruticoechea-Arana A; Martín-Martínez MA; Castañeda S; Piedra CA; González-Juanatey C; Llorca J; Díaz-Gonzalez F; González-Gay MA;
Arthritis Res Ther; 2015 Aug; 17(1):211. PubMed ID: 26271333
[TBL] [Abstract][Full Text] [Related]
9. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.
Gulati AM; Semb AG; Rollefstad S; Romundstad PR; Kavanaugh A; Gulati S; Haugeberg G; Hoff M
Ann Rheum Dis; 2016 May; 75(5):819-24. PubMed ID: 25814652
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.
Cioffi G; Viapiana O; Tarantini L; Orsolini G; Idolazzi L; Sonographer FO; Dalbeni A; Gatti D; Fassio A; Rossini M; Giollo A
Intern Emerg Med; 2021 Jun; 16(4):863-874. PubMed ID: 33083946
[TBL] [Abstract][Full Text] [Related]
11. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up.
Martín-Martínez MA; Castañeda S; Sánchez-Alonso F; García-Gómez C; González-Juanatey C; Sánchez-Costa JT; Belmonte-López MA; Tornero-Molina J; Santos-Rey J; Sánchez González CO; Quesada E; Moreno-Gil MP; Cobo-Ibáñez T; Pinto-Tasnde JA; Babío-Herráez J; Bonilla G; Juan-Mas A; Manero-Ruiz FJ; Romera-Baurés M; Bachiller-Corral J; Chamizo-Carmona E; Uriarte-Ecenarro M; Barbadillo C; Fernández-Carballido C; Aurrecoechea E; Möller-Parrera I; Llorca J; González-Gay MA;
Rheumatology (Oxford); 2021 Jun; 60(6):2906-2915. PubMed ID: 33254222
[TBL] [Abstract][Full Text] [Related]
13. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.
Michelsen B; Fiane R; Diamantopoulos AP; Soldal DM; Hansen IJ; Sokka T; Kavanaugh A; Haugeberg G
PLoS One; 2015; 10(4):e0123582. PubMed ID: 25853482
[TBL] [Abstract][Full Text] [Related]
14. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
[TBL] [Abstract][Full Text] [Related]
15. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis.
Jadon DR; Sengupta R; Nightingale A; Lindsay M; Korendowych E; Robinson G; Jobling A; Shaddick G; Bi J; Winchester R; Giles JT; McHugh NJ
Ann Rheum Dis; 2017 Apr; 76(4):701-707. PubMed ID: 27913376
[TBL] [Abstract][Full Text] [Related]
16. Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
Sheahan A; Anjohrin S; Suruki R; Stark JL; Sloan VS
Clin Rheumatol; 2024 Jun; 43(6):1897-1907. PubMed ID: 38658403
[TBL] [Abstract][Full Text] [Related]
17. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
[TBL] [Abstract][Full Text] [Related]
18. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
[TBL] [Abstract][Full Text] [Related]
19. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
